211 related articles for article (PubMed ID: 38510679)
1. Slowly progressive cell death induced by GPx4-deficiency occurs via MEK1/ERK2 activation as a downstream signal after iron-independent lipid peroxidation.
Tsuruta K; Matsuoka M; Harada S; Enomoto A; Kumagai T; Yasuda S; Koumura T; Yamada KI; Imai H
J Clin Biochem Nutr; 2024 Mar; 74(2):97-107. PubMed ID: 38510679
[TBL] [Abstract][Full Text] [Related]
2. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
[TBL] [Abstract][Full Text] [Related]
3. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
[TBL] [Abstract][Full Text] [Related]
4. RSL3 and Erastin differentially regulate redox signaling to promote Smac mimetic-induced cell death.
Dächert J; Schoeneberger H; Rohde K; Fulda S
Oncotarget; 2016 Sep; 7(39):63779-63792. PubMed ID: 27588473
[TBL] [Abstract][Full Text] [Related]
5. NCOA4-mediated ferritinophagy promotes ferroptosis induced by erastin, but not by RSL3 in HeLa cells.
Gryzik M; Asperti M; Denardo A; Arosio P; Poli M
Biochim Biophys Acta Mol Cell Res; 2021 Feb; 1868(2):118913. PubMed ID: 33245979
[TBL] [Abstract][Full Text] [Related]
6. GPX4 overexpressed non-small cell lung cancer cells are sensitive to RSL3-induced ferroptosis.
Kim JW; Min DW; Kim D; Kim J; Kim MJ; Lim H; Lee JY
Sci Rep; 2023 May; 13(1):8872. PubMed ID: 37258589
[TBL] [Abstract][Full Text] [Related]
7. Theaflavin-3,3'-Digallate Inhibits Erastin-Induced Chondrocytes Ferroptosis via the Nrf2/GPX4 Signaling Pathway in Osteoarthritis.
Xu C; Ni S; Xu N; Yin G; Yu Y; Zhou B; Zhao G; Wang L; Zhu R; Jiang S; Wang Y
Oxid Med Cell Longev; 2022; 2022():3531995. PubMed ID: 36439689
[TBL] [Abstract][Full Text] [Related]
8. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1.
Cheff DM; Huang C; Scholzen KC; Gencheva R; Ronzetti MH; Cheng Q; Hall MD; Arnér ESJ
Redox Biol; 2023 Jun; 62():102703. PubMed ID: 37087975
[TBL] [Abstract][Full Text] [Related]
9. Everolimus accelerates Erastin and RSL3-induced ferroptosis in renal cell carcinoma.
Yangyun W; Guowei S; Shufen S; Jie Y; Rui Y; Yu R
Gene; 2022 Jan; 809():145992. PubMed ID: 34648917
[TBL] [Abstract][Full Text] [Related]
10. Lipid Peroxidation and GPX4 Inhibition Are Common Causes for Myofibroblast Differentiation and Ferroptosis.
Gong Y; Wang N; Liu N; Dong H
DNA Cell Biol; 2019 Jul; 38(7):725-733. PubMed ID: 31140862
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Nrf2 Signalling and the Inhibition of Erastin-Induced Ferroptosis by Ferulic Acid in MIN6 Cells.
Kose T; Sharp PA; Latunde-Dada GO
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555529
[TBL] [Abstract][Full Text] [Related]
12. Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer.
Park SY; Jeong KJ; Poire A; Zhang D; Tsang YH; Blucher AS; Mills GB
Cell Death Dis; 2023 Aug; 14(8):532. PubMed ID: 37596261
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial event as an ultimate step in ferroptosis.
Oh SJ; Ikeda M; Ide T; Hur KY; Lee MS
Cell Death Discov; 2022 Oct; 8(1):414. PubMed ID: 36209144
[TBL] [Abstract][Full Text] [Related]
14. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia.
Feng S; Yuan Y; Lin Z; Li M; Ye D; Shi L; Li D; Zhao M; Meng C; He X; Wu S; Xiong F; Ye S; Yang J; Zhuang H; Hong L; Gao S
Exp Hematol Oncol; 2024 Feb; 13(1):19. PubMed ID: 38378601
[TBL] [Abstract][Full Text] [Related]
15. Curcumin and (-)- Epigallocatechin-3-Gallate Protect Murine MIN6 Pancreatic Beta-Cells Against Iron Toxicity and Erastin-Induced Ferroptosis.
Kose T; Vera-Aviles M; Sharp PA; Latunde-Dada GO
Pharmaceuticals (Basel); 2019 Feb; 12(1):. PubMed ID: 30736288
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis: An emerging therapeutic opportunity for cancer.
Wang L; Chen X; Yan C
Genes Dis; 2022 Mar; 9(2):334-346. PubMed ID: 35224150
[TBL] [Abstract][Full Text] [Related]
17. A novel anticancer property of
DU X; Zhang J; Liu L; Xu B; Han H; Dai W; Pei X; Fu X; Hou S
J Zhejiang Univ Sci B; 2022 Apr; 23(4):286-299. PubMed ID: 35403384
[TBL] [Abstract][Full Text] [Related]
18. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3.
Shintoku R; Takigawa Y; Yamada K; Kubota C; Yoshimoto Y; Takeuchi T; Koshiishi I; Torii S
Cancer Sci; 2017 Nov; 108(11):2187-2194. PubMed ID: 28837253
[TBL] [Abstract][Full Text] [Related]
19. Ryanodine Receptor Mediated Calcium Release Contributes to Ferroptosis Induced in Primary Hippocampal Neurons by GPX4 Inhibition.
Gleitze S; Ramírez OA; Vega-Vásquez I; Yan J; Lobos P; Bading H; Núñez MT; Paula-Lima A; Hidalgo C
Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978954
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
